NCT07169344 2026-01-28
PROSARC-1
Oslo University Hospital
Phase 2 Recruiting
Clinical Trials
8 trialsNCT05932667 2023-12-21
DEMETER
Institut Curie
Phase 2 Terminated
NCT05157451 2023-03-23
Y-90 Versus SBRT for Inoperable HCC
OHSU Knight Cancer Institute
Phase 2 Withdrawn
NCT01928485 2020-10-22
Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT03628144 2020-09-10
Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Withdrawn
NCT00814463 2019-02-26
Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases
Duke University
Phase 2 Terminated
NCT00667394 2015-11-05
Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00712621 2009-11-24
Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination
American Scitech International
Phase 2 Withdrawn